The World Health Organisation (WHO) has disclosed plans to establish a Vaccine Accelerator Council to speed up the licensing and use of effective novel vaccines against Tuberculosis (TB). The new council is intended to bring together funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development, the global health agency said. Sole vaccineThe global body further said that the Bacillus Calmette-Guérin (BCG) vaccine, developed in 1921, is the only licensed TB vaccine. Meanwhile, a vaccine with 75 per cent efficacy could avert up to 110 million new TB cases and 12.3 million deaths. The study further suggests that every US$1 invested in a 50 per cent effective vaccine could generate an economic return of US$ 7 in terms of averted health costs and increased productivity.
Continue reading...